These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
366 related items for PubMed ID: 16449001
21. Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients. Noskin G, Pietrelli L, Gurwith M, Bowden R. Bone Marrow Transplant; 1999 Apr; 23(7):697-703. PubMed ID: 10218847 [Abstract] [Full Text] [Related]
22. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation. Borro JM, Solé A, de la Torre M, Pastor A, Fernandez R, Saura A, Delgado M, Monte E, Gonzalez D. Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204 [Abstract] [Full Text] [Related]
23. Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients. Miller CB, Waller EK, Klingemann HG, Dignani MC, Anaissie EJ, Cagnoni PJ, McSweeney P, Fleck PR, Fruchtman SM, McGuirk J, Chao NJ. Bone Marrow Transplant; 2004 Mar; 33(5):543-8. PubMed ID: 14730342 [Abstract] [Full Text] [Related]
28. Acrocyanosis developed with amphotericin B deoxycholate but not with amphotericin B lipid complex. Ozaras R, Yemisen M, Mete B, Mert A, Ozturk R, Tabak F. Mycoses; 2007 May; 50(3):242. PubMed ID: 17472626 [No Abstract] [Full Text] [Related]
29. [Clinical study of amphotericin B in the treatment of invasive fungal infection in 111 hematological disorder patients with neutrocytopenia]. Tong HY, Zhang FJ, Xiao F, Qian WB, Meng HT, Mai WY, Tong Y, Mao LP, Jin J. Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):472-5. PubMed ID: 19035181 [Abstract] [Full Text] [Related]
36. Amphotericin B deoxycholate for candidiasis in intensive care unit patients revisited: medical, ethical, and financial implications. Dreyfuss D, Ricard JD, Gaudry S. Am J Respir Crit Care Med; 2013 Mar 15; 187(6):661-3. PubMed ID: 23504365 [No Abstract] [Full Text] [Related]
38. Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study. Falci DR, da Rosa FB, Pasqualotto AC. Mycoses; 2015 Feb 15; 58(2):104-12. PubMed ID: 25590436 [Abstract] [Full Text] [Related]
39. A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis. Le T, Kinh NV, Cuc NTK, Tung NLN, Lam NT, Thuy PTT, Cuong DD, Phuc PTH, Vinh VH, Hanh DTH, Tam VV, Thanh NT, Thuy TP, Hang NT, Long HB, Nhan HT, Wertheim HFL, Merson L, Shikuma C, Day JN, Chau NVV, Farrar J, Thwaites G, Wolbers M, IVAP Investigators. N Engl J Med; 2017 Jun 15; 376(24):2329-2340. PubMed ID: 28614691 [Abstract] [Full Text] [Related]
40. Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study. Imhof A, Walter RB, Schaffner A. Clin Infect Dis; 2003 Apr 15; 36(8):943-51. PubMed ID: 12684904 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]